FDA-Inspected Site

Pfizer Inc.

8 FDA inspections are on record for Pfizer Inc. in Groton, United States.

483· Form 483 issued

Groton, United States · Last updated July 9, 2026

Overview

  • 8 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-12-13.

At a glance

Inspections

8

Form 483s

5

EIRs

4

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Dec 2024 – 13 Dec 2024Human Drugs483View 483 →
26 Aug 2024 – 30 Aug 2024Human DrugsClean
4 Jan 2021 – 8 Jan 2021Human DrugsClean
11 Sep 2017 – 22 Sep 2017Human Drugs483View 483 →
16 Sep 2014 – 30 Sep 2014Human Drugs483On file
23 Aug 2012Not recordedClean
27 Oct 2010Not recorded483On file
8 May 2009Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

13 Dec 2024
21 CFR 58.130(a)

Conduct: in accordance with protocol

Cited by Matthew C Watson, Erin M Mcdowell

13 Dec 2024
21 CFR 58.33(f)

Study director: transfer of data to archives

Cited by Matthew C Watson, Erin M Mcdowell

22 Sep 2017
21 CFR 58.190(a)

Archives: data, documentation, specimens

Cited by Kent A Conforti

22 Sep 2017
21 CFR 58.63(c)

Equipment: maintenance records

Cited by Kent A Conforti

Investigators

FDA investigators tied to this site in the record.

M. P Murphy2 insp.
Susanne M Richardson1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 58.130(a)Cited across public-safe Form 483 observations1x
21 CFR 58.190(a)Cited across public-safe Form 483 observations1x
21 CFR 58.33(f)Cited across public-safe Form 483 observations1x
21 CFR 58.63(c)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Pfizer Inc.'s 5 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat